title: Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer.
abstract: Intrauterine and perinatal factors have been linked to risk of childhood leukemia, testicular cancer, and breast cancer in the offspring. The pool of stem cells in target tissue has been suggested as a critical factor linking early life exposures to cancer. We examined the relation between intrauterine hormone levels and measurements of stem cell potential in umbilical cord blood. Cord blood donors were 40 women, ages >/=18 years, who delivered, from August 2002 to June 2003, a singleton birth after a gestation of at least 37 weeks. We assayed plasma concentrations of estradiol, unconjugated estriol, testosterone, progesterone, prolactin, sex hormone binding globulin, insulin-like growth factor-I (IGF-I), and IGF binding protein-3. For stem cell potential, we measured concentrations of CD34(+) and CD34(+)CD38(-) cells and granulocyte-macrophage colony-forming unit (CFU-GM). We applied linear regression analysis and controlled for maternal and neonatal characteristics. We found strong positive associations between IGF-I and stem cell measures, 1 SD increase in IGF-I being associated with a 41% increase in CD34(+) (P = 0.008), a 109% increase in CD34(+)CD38(-) (P = 0.005), and a 94% increase in CFU-GM (P = 0.01). Similar associations were observed for IGF binding protein-3. Among steroid hormones, estriol and testosterone were significantly positively associated with CD34(+) and CFU-GM. These findings indicate that levels of growth factors and hormones are strongly associated with stem cell potential in human umbilical cord blood and point to a potential mechanism that may mediate the relationship between in utero exposure to hormones and cancer risk in the offspring.
authors.affiliation: Cancer Research Center and Department of Cancer Biology, ILAT Steroid RIA Laboratory, University of Massachusetts Medical School, Worchester, MA 01605, USA.
authors.forename: Inkyung
authors.initials: I
authors.lastname: Baik
authors.forename: William J
authors.initials: WJ
authors.lastname: Devito
authors.forename: Karen
authors.initials: K
authors.lastname: Ballen
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Becker
authors.forename: William
authors.initials: W
authors.lastname: Okulicz
authors.forename: Qin
authors.initials: Q
authors.lastname: Liu
authors.forename: Ellen
authors.initials: E
authors.lastname: Delpapa
authors.forename: Pagona
authors.initials: P
authors.lastname: Lagiou
authors.forename: Susan
authors.initials: S
authors.lastname: Sturgeon
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Trichopoulos
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Quesenberry
authors.forename: Chung-Cheng
authors.initials: CC
authors.lastname: Hsieh
mesh_terms: D015703:Antigens, CD / Q000097:blood; D018952:Antigens, CD34 / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000737:chemistry* / Q000166:cytology*; D005865:Gestational Age; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006728:Hormones / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009369:Neoplasms / Q000453:epidemiology*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D044469:Racial Groups; D012307:Risk Factors; D014481:United States
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D006728:Hormones